BMO Capital Remains Sidelined on United Natural Foods (UNFI) Following 1Q EPS Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
RBC Keeps United Natural Foods (UNFI) at 'Sector Perform' Following Q1 Report; Notes Cloudier Visibility
December 8, 2016 1:34 PM ESTRBC Capital reaffirms United Natural Foods (Nasdaq: UNFI) at Sector Perform with a price target of $34 following Q1 results issued yesterday.
Following: 1) an earnings miss; 2) the largest EBIT margin contraction in three quarters; 3) an organic growth deceleration; 4) less visibility into fundamentals; and... More
Guggenheim Reiterates Buy on United Natural Foods (UNFI) Following 1Q Report
December 8, 2016 8:44 AM ESTGuggenheim reiterated a Buy rating on United Natural Foods (NASDAQ: UNFI), and raised the price target to $52.00 (from $47.00), following the company's 1Q earnings report. EBIT came in $3 million light on lower-than-expected sales growth and EPS of $0.58 missed expectations by $0.04.
Analyst John Heinbockel... More
After-Hours Stock Movers 12/07: (VYGR) (LULU) (HRB( Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
December 7, 2016 7:04 PM ESTToday's After-Hours Movers:
Voyager Therapeutics, Inc. (Nasdaq: VYGR) 35.2% HIGHER; announced positive results from the ongoing Phase 1b trial of VY-AADC01 at six and twelve months of follow-up in patients with advanced Parkinsons disease. The interim data from Cohorts 1 and 2 of this trial demonstrated that accurate MRI-guided delivery of escalating doses of VY-AADC01 were well tolerated and resulted in increased coverage of the putamen, increased AADC enzyme activity, enhanced response to levodopa, and dose-related, clinically meaningful improvements in various measures of patients motor function. This was... More
United Natural Foods (UNFI) Misses Q1 EPS by 4c, Reaffirms FY Guiance
December 7, 2016 4:15 PM ESTUnited Natural Foods (NASDAQ: UNFI) reported Q1 EPS of $0.58, $0.04 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $2.28 billion versus the consensus estimate of $2.32 billion.
United Natural Foods reaffirmed FY2016 guidance.
For earnings history and earnings-related data on United Natural Foods (UNFI) click here.
... MoreTrading Radar for 12/7: lululemon (LULU), SecureWorks (SCWX), Vera Bradley (VRA), Tailored Brands (TLRD) Report
December 6, 2016 1:55 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
Brown-Forman (NYSE: BF-B) - consensus EPS $0.50
Hooker Furniture (Nasdaq: HOFT) - consensus EPS $0.46
John... More

